Diversity Golden Ticket Winners

We are proud to announce Olfera and Opal Therapeutics as the winners of this year's Diversity Golden Ticket. Congratulations to both teams!

Delve Bio was selected by BioSpace as a member of their “NextGen Class of 2024: Top Life Sciences Startups to Watch This Year”

Lunch and Learn with Agilent: Fall in Love with Cytation!

February 14 @ noon - 12:40pm
930 Brittan Ave, San Carlos

Discover how the Cytation 5 can automate your imaging assays this Valentine’s Day.

Life Science Vendor's Showcase

February 21 @ 10am - 2pm
135 Mississippi St, San Francisco

Please join us for the 2024 Life Science Vendor’s Showcase! Bringing together the latest technologies and services from a variety of external vendors, this is an opportunity to explore new tools, techniques, resources and network with other members of the life science community. We hope to see you there!

Come Hear Resident Company, CacheDNA, Speak to Our Community!

February 29, @ 4 PM
733 Industrial Rd, San Carlos

Our upcoming Founders at Work Speakers feature CacheDNA's Michael Becich, CEO and Heather Williams, VP of Clinical Genomics. Cache DNA is revolutionizing the way biomolecules are stored and accessed - offering a groundbreaking technology for unlimited storage and rapid retrieval of nucleic acids, without the need for energy.

Malvern Panalytical Workshop: Orthogonal Techniques For Protein Drug Discovery Programs

March 20 @ 10 AM - 3:30 PM
135 Mississippi St, San Francisco

Please join us for a free in-person workshop with our partners at Malvern Panalytical and learn about new orthogonal discovery techniques, in addition to demos of the Microcal PEAQ-DSC and PEAQ-ITC located in our cores!

Partner Office Hours

Looking to connect with Sartorius, Agilent, Revvity, or Thermo Fisher Scientific - and enjoy a free treat? Check times and locations on our Partner calendar.

RevOpsis

RevOpsis Therapeutics is a next-generation biopharmaceutical company focused on solving blindness with a vision for the rapid discovery and development of novel therapies using their modular Rev-Mod Platform. Their therapeutic candidates - Multi-Mod biologics - are specifically designed to achieve improved disease outcomes and extended disease remission by targeting multiple dominant biologic pathways in complex multifactorial diseases. RevOpsis will be joining the 733 Industrial Community in San Carlos.

Epi Labs

There are more than 100 genes we can upregulate or downregulate to extend lifespan in mice by up to 46% when regulated alone (and more is possible in combinations!). All of these genes are found in humans but most have never been clinically translated. Epi Labs Inc is a pre-seed stage startup, backed by age1, working on epigenetic editors for the targets of lifespan and complex diseases. They will be joining our 135 Mississippi Street community.

Parcel Bio

ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Our nanoparticle-free, non-viral delivery platform works by stabilizing the mRNA and using an interchangeable, lock-and-key-like targeting mechanism to enable fully programmable mRNA medicines. ParcelBio was founded by leading innovators in mRNA therapeutics and is backed by Y Combinator. Epi Labs will be joining the 135 Mississippi Street Community.

Montara Therapeutics

Montara Therapeutics, is a San Francisco–based precision-medicine neuroscience biotech startup. The Montara team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). Their mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy. We are happy to welcome Montara to our 135 Mississippi Community!